1Liaw YF. Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B[J]. Antivir Chem Chemother,2001,12supple:67.
2Hadziyannis SJ,Papatheodoridis GV ,Dimou E,et al.Efficacy of long-term lamivudine monotherapy in patients with hepatitis B eanti-gen-negative chronic hepatitis B[J]. Hepatology,2000,32:847.
4Humphries JC,Dixon JS.Antivirals for treatment of chronic hepatitis B:current and future options[J]. Intervirology,2003,46:413.
5Liaw YF.Results of Lamivudine trials in Asia[J]. J Hepatol,2003,39(1): 111.
6Lai CL,Dienstag J,Schiff E,et al. Prevalence and clinical correlates of YMMD bariants during lamivudine therapy for patients with chronic hep^- atitis B[J]. CAin Infect Dis,2003,36:687.
